Petula Pharmaceuticals Private Limited
About Petula Pharmaceuticals Private Limited
Data last updated:
Petula Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74120DL2007PTC163872. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prajwal Arora and Namrata Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 First Floor Vigyan Lok Shreshtha Vihar, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹30,500. For the same year it recorded a net loss of ₹49,803 (net margin -163.3%) and EBITDA of ₹8,767 (EBITDA margin 28.7%). Revenue has declined at a compounded annual rate (CAGR) of 44% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Petula Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address21 First Floor Vigyan Lok Shreshtha Vihar, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Petula Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Petula Pharmaceuticals Private Limited
FY 2025 filings availablePetula Pharmaceuticals Private Limited reported revenue of ₹30,500 for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 44% over five years. EBITDA rose 162% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,767 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹49,803 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.7% | ||||
| Net Profit Margin | -163.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Petula Pharmaceuticals Private Limited, buy the company report.
Board of directors of Petula Pharmaceuticals Private Limited
Petula Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prajwal Arora | Director | 27 Dec 2022 | 3 Years 9 Months | Current |
| Namrata Arora | Director | 21 Aug 2024 | 2 Years 2 Months | Current |
Peer comparison
Petula Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Baldwin Pharmaceuticals Private Limited | ₹31,063 (FY 2022) | -58.0% | Jammu, Jammu and Kashmir, India | |||
| Marshall Hospital Private Limited | ₹31,022 (FY 2025) | -93.0% | New Delhi, Delhi, India | |||
| Sunvill Healthcare Private Limited | ₹31,000 (FY 2023) | Baddi, Himachal Pradesh, India | ||||
| Kingbuild Pharmaceuticals Private Limited | ₹30,800 (FY 2021) | -52.0% | Surat, Gujarat, India | |||
| Apg Needles Pvt Ltd | ₹30,738 (FY 2024) | -100.0% | New Delhi, Delhi, India | |||
| Petula Pharmaceuticals Private Limitedthis company | ₹30,500 (FY 2024) | -₹49,803 | -163.3% | Delhi, India | ||
| Pharmagate Lifesciences Private Limited | ₹30,380 (FY 2025) | 667.0% | Ambarnath, Maharashtra, India | |||
| Supreme Global Health Care Private Limited | ₹30,225 (FY 2022) | -68.0% | Nagpur, Maharashtra, India | |||
| Westal Pharmaceuticals Private Limited | ₹30,143 (FY 2021) | -80.0% | Agra, Uttar Pradesh, India | |||
| Sact Pharmaceuticals Private Limited | ₹30,120 (FY 2021) | Varanasi, Uttar Pradesh, India | ||||
| Societa Cofica Chemicals India Private Limited | ₹30,070 (FY 2025) | -1.0% | New Delhi, Delhi, India |
To see the full peer comparison of Petula Pharmaceuticals Private Limited, buy the company report.
Auditor
Petula Pharmaceuticals Private Limited is audited by K N L & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K N L & CO | FY 2018 | 028496N |
Shareholding
The shareholding of Petula Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Petula Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Petula Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Petula Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Petula Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Petula Pharmaceuticals Private Limited, buy the company report.
Recent activity
Petula Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Namrata Arora was appointed as Director on 21 Aug 2024.
Frequently asked questions
Petula Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 May 2007 (19+ years old) and is registered under CIN U74120DL2007PTC163872.
Petula Pharmaceuticals has 2 current directors:
- Prajwal Arora - Director
- Namrata Arora - Director
The latest financial statements of Petula Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Petula Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Petula Pharmaceuticals is U74120DL2007PTC163872. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Petula Pharmaceuticals was incorporated on 24 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Petula Pharmaceuticals by revenue are Baldwin Pharmaceuticals Private Limited, Marshall Hospital Private Limited, Sunvill Healthcare Private Limited, Kingbuild Pharmaceuticals Private Limited, Apg Needles Pvt Ltd and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Namrata Arora was appointed as Director on 21 Aug 2024. Praveen Kumar ceased to be Director on 21 Aug 2024. Namrata Arora ceased to be Director on 27 Dec 2022. Petula Pharmaceuticals has 4 board changes on record in total.
The registered office of Petula Pharmaceuticals is at 21 First Floor Vigyan Lok Shreshtha Vihar, Delhi, India – 110092.
Petula Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Petula Pharmaceuticals is compliant as of 02 September 2026. The company is actively filing with the Registrar of Companies.